BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Krishnan A, Nair SA, Pillai MR. Loss of cks1 homeostasis deregulates cell division cycle. J Cell Mol Med 2010;14:154-64. [PMID: 19228269 DOI: 10.1111/j.1582-4934.2009.00698.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Xu L, Fan S, Zhao J, Zhou P, Chu S, Luo J, Wen Q, Chen L, Wen S, Wang L, Shi L. Increased expression of Cks1 protein is associated with lymph node metastasis and poor prognosis in nasopharyngeal carcinoma. Diagn Pathol 2017;12:2. [PMID: 28061788 DOI: 10.1186/s13000-016-0589-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
2 Maes A, Menu E, Veirman K, Maes K, Vand Erkerken K, De Bruyne E. The therapeutic potential of cell cycle targeting in multiple myeloma. Oncotarget 2017;8:90501-20. [PMID: 29163849 DOI: 10.18632/oncotarget.18765] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
3 Mi G, Gao Y, Liu S, Ye E, Li Y, Jin X, Yang H, Yang Z. Cyclin-dependent kinase inhibitor flavopiridol promotes remyelination in a cuprizone induced demyelination model. Cell Cycle 2016;15:2780-91. [PMID: 27580304 DOI: 10.1080/15384101.2016.1220458] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
4 Carreras J, Kikuti YY, Beà S, Miyaoka M, Hiraiwa S, Ikoma H, Nagao R, Tomita S, Martin-garcia D, Salaverria I, Sato A, Ichiki A, Roncador G, Garcia JF, Ando K, Campo E, Nakamura N. Clinicopathological characteristics and genomic profile of primary sinonasal tract diffuse large B cell lymphoma (DLBCL) reveals gain at 1q31 and RGS1 encoding protein; high RGS1 immunohistochemical expression associates with poor overall survival in DLBC. Histopathology 2017;70:595-621. [DOI: 10.1111/his.13106] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
5 Hamdi A, Lesnard A, Suzanne P, Robert T, Miteva MA, Pellerano M, Didier B, Ficko-blean E, Lobstein A, Hibert M, Rault S, Morris MC, Colas P. Tampering with Cell Division by Using Small-Molecule Inhibitors of CDK-CKS Protein Interactions. ChemBioChem 2015;16:432-9. [DOI: 10.1002/cbic.201402579] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
6 Xu J, Xu T, Yang Y, Wang W, Li J, Ren Y, Gu S, Chen C, Wei Z, Zhuang J, Wang Z, Ji L, Cheng L, Wang W, Cheng Z, Ke Y, Yuan L, Liu P. The paradoxical prognostic role of 1q21 Gain/Amplification in multiple myeloma: every coin has two sides. Leukemia & Lymphoma 2020;61:2351-64. [DOI: 10.1080/10428194.2020.1772473] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Pavlides SC, Lecanda J, Daubriac J, Pandya UM, Gama P, Blank S, Mittal K, Shukla P, Gold LI. TGF-β activates APC through Cdh1 binding for Cks1 and Skp2 proteasomal destruction stabilizing p27kip1 for normal endometrial growth. Cell Cycle 2016;15:931-47. [PMID: 26963853 DOI: 10.1080/15384101.2016.1150393] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
8 Asmamaw MD, Liu Y, Zheng YC, Shi XJ, Liu HM. Skp2 in the ubiquitin-proteasome system: A comprehensive review. Med Res Rev 2020;40:1920-49. [PMID: 32391596 DOI: 10.1002/med.21675] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
9 Khattar V, Thottassery JV. Cks1: Structure, Emerging Roles and Implications in Multiple Cancers. J Cancer Ther 2013;4:1341-54. [PMID: 24563807 DOI: 10.4236/jct.2013.48159] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
10 Krishnan A, K D, Babu P.s S, Jagadeeshan S, Prasad M, Nair SA. Oncogenic Actions of SKP2 Involves Deregulation of CDK1 Turnover Mediated by FOXM1: O NCOGENIC A CTIONS OF skp2. J Cell Biochem 2017;118:797-807. [DOI: 10.1002/jcb.25754] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
11 Kashkin K, Chernov I, Stukacheva E, Monastyrskaya G, Uspenskaya N, Kopantzev E, Sverdlov E. Cancer specificity of promoters of the genes controlling cell proliferation. J Cell Biochem 2015;116:299-309. [PMID: 25187488 DOI: 10.1002/jcb.24968] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Huang J, Zhou Y, Thomas GS, Gu Z, Yang Y, Xu H, Tricot G, Zhan F. NEDD8 Inhibition Overcomes CKS1B-Induced Drug Resistance by Upregulation of p21 in Multiple Myeloma. Clin Cancer Res 2015;21:5532-42. [PMID: 26156395 DOI: 10.1158/1078-0432.CCR-15-0254] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
13 Heptinstall AB, Adiyasa I, Cano C, Hardcastle IR. Recent advances in CDK inhibitors for cancer therapy. Future Medicinal Chemistry 2018;10:1369-88. [DOI: 10.4155/fmc-2017-0246] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
14 Suber TL, Nikolli I, O'Brien ME, Londino J, Zhao J, Chen K, Mallampalli RK, Zhao Y. FBXO17 promotes cell proliferation through activation of Akt in lung adenocarcinoma cells. Respir Res 2018;19:206. [PMID: 30359271 DOI: 10.1186/s12931-018-0910-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
15 Cao C, Liu T, Zhu H, Wang L, Kai S, Xiang B. Bortezomib-Contained Chemotherapy and Thalidomide Combined With CHOP (Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone) Play Promising Roles in Plasmablastic Lymphoma: A Case Report and Literature Review. Clinical Lymphoma Myeloma and Leukemia 2014;14:e145-50. [DOI: 10.1016/j.clml.2014.03.002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
16 Rizzardi LF, Cook JG. Flipping the switch from g1 to s phase with e3 ubiquitin ligases. Genes Cancer 2012;3:634-48. [PMID: 23634252 DOI: 10.1177/1947601912473307] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
17 Kang YS, Jeong EJ, Seok HJ, Kim SK, Hwang JS, Choi ML, Jo DG, Kim Y, Choi J, Lee YJ, Jung E, Min JK, Han TS, Kim JS. Cks1 regulates human hepatocellular carcinoma cell progression through osteopontin expression. Biochem Biophys Res Commun 2019;508:275-81. [PMID: 30497779 DOI: 10.1016/j.bbrc.2018.11.070] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
18 Hu K, Li XJ, Asmamaw MD, Shi XJ, Liu HM. Establishment of high-throughput screening HTRF assay for identification small molecule inhibitors of Skp2-Cks1. Sci Rep 2021;11:21105. [PMID: 34702937 DOI: 10.1038/s41598-021-00646-3] [Reference Citation Analysis]
19 Kapatai G, Brundler MA, Jenkinson H, Kearns P, Parulekar M, Peet AC, McConville CM. Gene expression profiling identifies different sub-types of retinoblastoma. Br J Cancer 2013;109:512-25. [PMID: 23756868 DOI: 10.1038/bjc.2013.283] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 5.0] [Reference Citation Analysis]
20 Shi W, Huang Q, Xie J, Wang H, Yu X, Zhou Y. CKS1B as Drug Resistance-Inducing Gene-A Potential Target to Improve Cancer Therapy. Front Oncol 2020;10:582451. [PMID: 33102238 DOI: 10.3389/fonc.2020.582451] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Jones MC, Askari JA, Humphries JD, Humphries MJ. Cell adhesion is regulated by CDK1 during the cell cycle. J Cell Biol 2018;217:3203-18. [PMID: 29930204 DOI: 10.1083/jcb.201802088] [Cited by in Crossref: 60] [Cited by in F6Publishing: 47] [Article Influence: 20.0] [Reference Citation Analysis]
22 Stueckle TA, Lu Y, Davis ME, Wang L, Jiang BH, Holaskova I, Schafer R, Barnett JB, Rojanasakul Y. Chronic occupational exposure to arsenic induces carcinogenic gene signaling networks and neoplastic transformation in human lung epithelial cells. Toxicol Appl Pharmacol 2012;261:204-16. [PMID: 22521957 DOI: 10.1016/j.taap.2012.04.003] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 6.1] [Reference Citation Analysis]